Shane R. Stecklein

1.5k total citations
52 papers, 934 citations indexed

About

Shane R. Stecklein is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Shane R. Stecklein has authored 52 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 23 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Shane R. Stecklein's work include Breast Cancer Treatment Studies (17 papers), Cancer Immunotherapy and Biomarkers (11 papers) and BRCA gene mutations in cancer (10 papers). Shane R. Stecklein is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Cancer Immunotherapy and Biomarkers (11 papers) and BRCA gene mutations in cancer (10 papers). Shane R. Stecklein collaborates with scholars based in United States, Belgium and Australia. Shane R. Stecklein's co-authors include Roy A. Jensen, Priyanka Sharma, Easwari Kumaraswamy, Andrew K. Godwin, Fariba Behbod, Patricia J. Eifel, Ann H. Klopp, Michael Frumovitz, Bruce F. Kimler and Qamar J. Khan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Shane R. Stecklein

49 papers receiving 925 citations

Peers

Countries citing papers authored by Shane R. Stecklein

Since Specialization

Citations

This map shows the geographic impact of Shane R. Stecklein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane R. Stecklein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane R. Stecklein more than expected).

Fields of papers citing papers by Shane R. Stecklein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane R. Stecklein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane R. Stecklein. The network helps show where Shane R. Stecklein may publish in the future.

Co-authorship network of co-authors of Shane R. Stecklein

This figure shows the co-authorship network connecting the top 25 collaborators of Shane R. Stecklein. A scholar is included among the top collaborators of Shane R. Stecklein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane R. Stecklein. Shane R. Stecklein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC). 2024 ·Journal of Clinical Oncology ·Shane R. Stecklein, (unknown), Roberto Salgado, Anne O’Dea, Lauren Nye, Kelsey E. Larson, (unknown), Ryan K. Rader, Rashna Madan, Rachel Yoder, Joshua M. Staley, (unknown), (unknown), Jamie L. Wagner, Christa Balanoff, (unknown), Leonidas E. Bantis, Andrew K. Godwin, Qamar J. Khan, Priyanka Sharma	3
2	A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, Alliance A221505) 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Jennifer Le‐Rademacher, (unknown), Eric K. Hansen, (unknown), Jairo Wagner, Iwa Kong, Jane M. Armer, D.W. Arthur, (unknown), M. K. Lee, (unknown), Maryam B. Lustberg, (unknown), (unknown), (unknown), David K. Gaffney, Shane R. Stecklein, M. Bernstein, (unknown)	11
3	Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial 2023 ·JAMA Oncology ·Reshma Jagsi, William E. Barlow, Wendy A. Woodward, Eileen P. Connolly, Reshma Mahtani, Dean A. Shumway, Corey Speers, Shane R. Stecklein, Youssef H. Zeidan, Hong Zhang, Priyanka Sharma, Lajos Pusztai, Gabriel N. Hortobágyi, Kevin Kalinsky	6
4	ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease 2023 ·npj Breast Cancer ·Shane R. Stecklein, Bruce F. Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M. Staley, Qamar J. Khan, Anne O’Dea, Lauren Nye, Manana Elia, Jaimie Heldstab, (unknown), Stephen Hyter, (unknown), Harsh B. Pathak, Andrew K. Godwin, Priyanka Sharma	16
5	Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD). 2023 ·Journal of Clinical Oncology ·Shane R. Stecklein, Devin C. Koestler, Nanda Kumar Yellapu, Rachel Yoder, Bruce F. Kimler, Joshua M. Staley, (unknown), Qamar J. Khan, Anne O’Dea, Lauren Nye, Manana Elia, Jaimie Heldstab, (unknown), Stephen Hyter, (unknown), Harsh B. Pathak, Andrew K. Godwin, Priyanka Sharma	3
6	Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials 2023 ·Cancer Research ·Priyanka Sharma, Shane R. Stecklein, Rachel Yoder, Joshua M. Staley, Roberto Salgado, Laia Paré, Benedetta Conte, Fara Brasó‐Maristany, Anne O’Dea, Lauren Nye, Manana Elia, (unknown), Gregory Crane, (unknown), Qamar J. Khan, Andrew K. Godwin, Aleix Prat	2
7	Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers 2023 ·The Breast ·(unknown), (unknown), Trine Tramm, Shane R. Stecklein, Navita Somaiah, Alex De Caluwé, Jonathan Klein, William T. Tran, Roberto Salgado	5
8	Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion 2021 ·Molecular Oncology ·Emilly S. Villodre, Xiaoding Hu, Richard Larson, Pascal Finetti, (unknown), (unknown), Shane R. Stecklein, Ginette S. Santiago-Sánchez, Savitri Krishnamurthy, Juhee Song, Xiaoping Su, Naoto T. Ueno, Debu Tripathy, Steven Van Laere, François Bertucci, Pablo E. Vivas‐Mejía, Wendy A. Woodward, Bisrat G. Debeb	27
9	Breast Radiation Therapy–Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Bhavana V. Chapman, Diane Liu, Yu Shen, (unknown), (unknown), Angelica M. Gutierrez‐Barrera, Shane R. Stecklein, Gabriel O. Sawakuchi, Scott J. Bright, Isabelle Bedrosian, Jennifer K. Litton, Benjamin D. Smith, Wendy A. Woodward, George H. Perkins, Karen E. Hoffman, Michael C. Stauder, Eric A. Strom, Banu Arun, Simona F. Shaitelman	4
10	Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Bhavana V. Chapman, Diane Liu, Yu Shen, (unknown), (unknown), Angelica M. Gutierrez‐Barrera, Shane R. Stecklein, Gabriel O. Sawakuchi, Scott J. Bright, Isabelle Bedrosian, Jennifer K. Litton, Benjamin D. Smith, Wendy A. Woodward, George H. Perkins, Karen E. Hoffman, Michael C. Stauder, Eric A. Strom, Banu Arun, Simona F. Shaitelman	1
11	Radiation Sciences Education in Africa: An Assessment of Current Training Practices and Evaluation of a High-Yield Course in Radiation Biology and Radiation Physics 2020 ·JCO Global Oncology ·Shane R. Stecklein, Cullen M. Taniguchi, A Melancon, Dorothy Lombe, Kennedy Lishimpi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laurence E. Court, (unknown), Michael E. Kupferman, Anuja Jhingran, Susan Msadabwe	8
12	Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach 2019 ·Practical Radiation Oncology ·Shane R. Stecklein, (unknown), (unknown), Audree B. Tadros, Anna Weiss, Sarah M. DeSnyder, Henry M. Kuerer, Mediget Teshome, Thomas A. Buchholz, Michael C. Stauder, Naoto T. Ueno, Anthony Lucci, Wendy A. Woodward	11
13	Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy 2018 ·Practical Radiation Oncology ·Shane R. Stecklein, Simona F. Shaitelman, Gildy V. Babiera, Isabelle Bedrosian, Dalliah M. Black, Matthew T. Ballo, (unknown), Eric A. Strom, Valerie Reed, Tomáš Dvořák, Benjamin D. Smith, Wendy A. Woodward, Karen E. Hoffman, Pamela J. Schlembach, (unknown), Christopher Nelson, Jinzhong Yang, (unknown), Shiva Dibaj, Elizabeth S. Bloom	12
14	Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Shane R. Stecklein, Minjeong Park, Diane D. Liu, (unknown), Abigail S. Caudle, Elizabeth A. Mittendorf, Carlos H. Bárcenas, Sarah S. Mougalian, Wendy A. Woodward, Vicente Valero, Ayşegül A. Şahin, Wei Yang, Simona F. Shaitelman	14
15	Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival 2017 ·Journal of Cancer ·Shane R. Stecklein, Jay P. Reddy, Adam R. Wolfe, Mirtha S. Lopez, Tamer M. Fouad, Bisrat G. Debeb, Naoto T. Ueno, Abenaa M. Brewster, Wendy A. Woodward	9
16	Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery 2017 ·Annals of Surgical Oncology ·(unknown), Audree B. Tadros, Anna Weiss, Carla L. Warneke, Sarah M. DeSnyder, Henry M. Kuerer, Naoto T. Ueno, Shane R. Stecklein, Wendy A. Woodward, Anthony Lucci	34
17	Patterns of recurrence and survival in neuroendocrine cervical cancer 2016 ·Gynecologic Oncology ·Shane R. Stecklein, Anuja Jhingran, Jennifer K. Burzawa, Preetha Ramalingam, Ann H. Klopp, Patricia J. Eifel, Michael Frumovitz	40
18	The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer 2014 ·PubMed ·Priyanka Sharma, Shane R. Stecklein, Bruce F. Kimler, Geetika Sethi, Brian K. Petroff, Teresa A. Phillips, Ossama Tawfik, Andrew K. Godwin, Roy A. Jensen	45
19	Emerging Functions of microRNA-146a/b in Development and Breast Cancer 2012 ·Journal of Mammary Gland Biology and Neoplasia ·(unknown), Shane R. Stecklein, Kelli E. Valdez, Fariba Behbod	15
20	Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology 2012 ·Translational research ·Shane R. Stecklein, Roy A. Jensen	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact